• Products
    • PreciseInhale®
      • Precision dosing
      • PreciseInhale® input: Inhaler
      • PreciseInhale® input: Nebulizer
      • White paper
    • DissolvIt ®
    • XposeALI ®
    • Nose-Only
    • Intratracheal
    • Technical specifications
  • Inhalation Research Services (IRS)
    • Aerosol characterization
    • DissolvIt®: in vitro dissolution
    • Isolated Perfused Lung (IPL)
      ex vivo
    • Intratracheal in vivo
    • Nose-Only in vivo
  • Publications
  • About
    • About Us
    • Our Customers
    • Our Team
    • Management
    • Board
    • Advisory Board
  • Webinars
  • Investors / investerare
    • Bolagsanalys
    • Pressmeddelanden
    • Prenumerera
    • IPO 2017
    • Finansering 2023
    • Finansiella rapporter
    • Kalender
    • Ägarlista
    • Bolagstämma
    • Bolagsstyrning
    • Presentationer
  • Contact
Inhalation
  • Products
    • PreciseInhale®
      • Precision dosing
      • PreciseInhale® input: Inhaler
      • PreciseInhale® input: Nebulizer
      • White paper
    • DissolvIt ®
    • XposeALI ®
    • Nose-Only
    • Intratracheal
    • Technical specifications
  • Inhalation Research Services (IRS)
    • Aerosol characterization
    • DissolvIt®: in vitro dissolution
    • Isolated Perfused Lung (IPL)
      ex vivo
    • Intratracheal in vivo
    • Nose-Only in vivo
  • Publications
  • About
    • About Us
    • Our Customers
    • Our Team
    • Management
    • Board
    • Advisory Board
  • Webinars
  • Investors / investerare
    • Bolagsanalys
    • Pressmeddelanden
    • Prenumerera
    • IPO 2017
    • Finansering 2023
    • Finansiella rapporter
    • Kalender
    • Ägarlista
    • Bolagstämma
    • Bolagsstyrning
    • Presentationer
  • Contact
  • Bolagsanalys
  • Pressmeddelanden
  • Prenumerera
  • IPO 2017
  • Finansering 2023
  • Finansiella rapporter
  • Kalender
  • Ägarlista
  • Bolagstämma
  • Bolagsstyrning
  • Presentationer

Finansering 2023

VIKTIG INFORMATION!
Informationen på denna del av Inhalation Sciences webbplats är inte avsedd för, och får inte, direkt eller indirekt, helt eller delvis, åtkommas av eller distribueras eller spridas till personer som bor eller befinner sig i USA (innefattande dess territorier och besittningar, varje stat i USA samt District of Columbia) (“USA”), Australien, Kanada, Nya Zeeland, Hongkong, Japan, Sydkorea, Singapore, Schweiz, Sydafrika, Ryssland, Belarus eller någon annan jurisdiktion där sådan åtgärd helt eller delvis är föremål för legala restriktioner, eller skulle kräva prospekt, registrering eller andra åtgärder än vad som följer av svensk rätt. Informationen på webbsidorna utgör inte något erbjudande avseende teckningsrätter, betalda tecknade aktier eller aktier utgivna av Inhalation Sciences (“Värdepapper”) till någon person i nämnda jurisdiktioner. Informationen på webbsidorna får inte heller vidarebefordras eller reproduceras på sätt som står i strid med sådana restriktioner eller skulle innebära sådana krav.
Inga Värdepapper har registrerats eller kommer att registreras enligt United States Securities Act från 1933 i dess nuvarande lydelse eller värdepapperslagstiftningen i någon delstat eller annan jurisdiktion i USA och får inte erbjudas, tecknas, utnyttjas, pantsättas, säljas, återförsäljas, tilldelas, levereras eller på annat sätt överföras, direkt eller indirekt, i eller till USA, förutom i enlighet med eventuella undantag som accepteras av Inhalation Sciences.
Inhalation Sciences förbehåller sig rätten att enligt eventuellt undantag acceptera teckning från en person som befinner sig i eller är skriven i en jurisdiktion där deltagande annars skulle kräva prospekt, registrering eller andra åtgärder än de som följer av svensk rätt.
Inom det Europeiska ekonomiska samarbetsområdet (“EES”) lämnas inget erbjudande till allmänheten av Värdepapper i något annat land än Sverige. I andra medlemsländer i den Europeiska Unionen (“EU”) kan ett sådant erbjudande endast lämnas i enlighet med undantag i Prospektförordningen (EU) 2017/1129 (“Prospektförordningen”).

 

Företrädesemission 2023

För att läsa erbjudandet, klicka här.

April 6 2023:
The Board of Directors of Inhalation Sciences resolves on a rights issue of approximately MSEK 17.1,
English Press Release here:
PM_offentliggorande_FE_20230405__ENGLISH

April 6, 2023:
Styrelsen för Inhalation Sciences beslutar om företrädesemission om cirka 17,1 MSEK.
Pressmeddelande på svenska här:
PM_offentliggorande_FE_20230405__SV

April 21, 2023:
Information Memorandum: 
 Inhalation Sciences_IM

Inhalation Sciences Folder:   Inhalation Sciences_Folder

Anmälningssedel:   Anmalningssedel_UF (1)

Länk för elektronisk teckning via emissionsinstitutet:   https://hagberg-aneborn.web.verified.eu/?company=ISAB

April 24
Länk till att teckna Avanza: https://www.avanza.se/erbjudanden/svara.html/1682068276354
Länk till att teckna Nordnet: https://www.nordnet.se/foretagshandelser/grupp/140659

Videos

Stockholm Corporate Finance Life Science Seminarium, Capital Markets Day, 2023

  • Q&A with ISAB CEO Manoush Masarrat (in Swedish)

  • CEO Manoush Masarrat presents Inhalation Sciences AB (in English)
    Watch the video here
Contact

Hälsovägen 7
Novum Floor 6, Elevator E
141 57 Huddinge, Sweden.
contact@inhalation.se
+46 (0) 705 625 195

Visitor entrance: Blickagången 6, Floor 6, Elevator E

Useful links
  • Products
    • PreciseInhale®
      • Precision dosing
      • PreciseInhale® input: Inhaler
      • PreciseInhale® input: Nebulizer
      • White paper
    • DissolvIt ®
    • XposeALI ®
    • Nose-Only
    • Intratracheal
    • Technical specifications
  • Inhalation Research Services (IRS)
    • Aerosol characterization
    • DissolvIt®: in vitro dissolution
    • Isolated Perfused Lung (IPL)
      ex vivo
    • Intratracheal in vivo
    • Nose-Only in vivo
  • Publications
  • About
    • About Us
    • Our Customers
    • Our Team
    • Management
    • Board
    • Advisory Board
  • Webinars
  • Investors / investerare
    • Bolagsanalys
    • Pressmeddelanden
    • Prenumerera
    • IPO 2017
    • Finansering 2023
    • Finansiella rapporter
    • Kalender
    • Ägarlista
    • Bolagstämma
    • Bolagsstyrning
    • Presentationer
  • Contact
About Us

Inhalation Sciences develops and sells patented, highly innovative labtech equipment for inhalation research. Scientists using it can now know, with unprecedented accuracy, how particles behave in our lungs when we inhale them: whether new pollutants or life-saving drugs that power human development.

Privacy policy

Copyright © 2023 Inhalation. All rights reserved.

Design mkmedia
Contact us!
To top

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Cookie Policy

Cookie Policy

At inhalation.se we use cookies as stated below. You can prevent the use of cookies at any time by pressing the icon down to your left, although this can influence your user experience on our website.

 

What are cookies?

Cookies are small text files that are placed on a computer by a web server and works just like an ID card. Cookies enable the website to remember important information, which makes your visit more convenient. Most websites use cookies to enhance the user experience and usability for you as a visitor. A cookie is a so-called passive file that can not spread dangerous software or viruses on your mobile device or computer. There are two types of cookies, permanent cookies and session cookies.

 

Permanent cookies

This cookie saves a file that remains on the user’s computer. The cookie is used to tailor a website to the user’s requirements, choices and interests, as well as for statistic follow-up, among other things.

 

Session cookies

While a visitor is on a website, this cookie is stored temporarily on the visitor’s computer. Session Cookies disappear when you close your web browser.

Cookies can be either first-party cookies or third-party cookies. First-party cookies are placed by the website you’re visiting while third-party cookies are placed by another part. Third-party cookies are often used by e.g. Google Analytics, Facebook and Remarketing with the purpose to understand how the website is used and to improve it, as well as to generate targeted advertising.

 

What cookies inhalation.se use and how to disable them

Read more about the cookies that are used on this website, their purpose, their lifespan and/or change the settings for them here.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

bscookie
Purpose: This cookie is a browser ID cookie set by Linked share Buttons and ad tags.
Domain: .www.linkedin.com
Lifespan: 2 years

lang
Purpose: This cookie is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
Domain: .ads.linkedin.com
Lifespan: session

bcookie
Purpose: This cookie is set by linkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
Domain: .linkedin.com
Lifespan: 2 years

lidc
Purpose: This cookie is set by LinkedIn and used for routing.
Domain: .linkedin.com
Lifespan: 1 day

UserMatchHistory
Purpose: Linkedin - Used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
Domain: .linkedin.com
Lifespan: 1 month

AnalyticsSyncHistory
Purpose: Used to store information about the time a sync took place with the lms_analytics cookie
Domain: .linkedin.com
Lifespan: 1 month

_gat
Purpose: Google Analytics, _”gat” is used in order to limit the number of inquiries which are made to inhalation.se
Domain: inhalation.se
Lifespan: Session

_ga
Purpose: Google Analytics, _”ga” This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report.
Domain: inhalation.se
Lifespan: 2 years

Please enable Strictly Necessary Cookies first so that we can save your preferences!